SEARCH
検索詳細
山田 亮
学長直属
教授
研究活動情報
■ 論文
■ 所属学協会
■ 共同研究・競争的資金等の研究課題
■ 共同研究希望
■ 共同研究実績
■ 研究者からの一言アピール
■ 関心を持って取組んでいる活動
- Evaluation of the Immunological Response of Childhood Cancer Patients Treated with a Personalized Peptide Vaccine for Refractory Soft Tissue Tumor: A Four-Case Series.
Keiko Oda; Yasuhiko Ito; Akira Yamada; Shigeru Yutani; Kyogo Itoh; Shuichi Ozono
The Kurume medical journal, 2023年07月03日 - Suppression of high mobility group box 1 in B16F10 tumor does not inhibit the induction of neoantigen-specific T cells.
Waki K, Ozawa M, Yamada A.
Cancer Sci, 2022年12月 - Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth.
Yokomizo K, Waki K, Ozawa M, Yamamoto K, Ogasawara S, Yano H, and Yamada A.
Med Oncol, 2022年02月 - Diversity and shared T-cell receptor repertoire analysis in esophageal squamous cell carcinoma.
Sudo T, Kawahara A, Ishi K, Mizoguchi A, Nagasu S, Nakagawa M, Fujisaki M, Hino H, Saisho K, Kaku H, Matono S, Mori N, Akiba J, Yamada A, Akagi Y.
Oncol Lett., 2021年08月 - Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer.
Uchino Y, Muroya D, Yoshitomi M, Shichijo S, Yamada A, Sasada T, Yamada T, Okuda K, Itoh K, Yutani S.
Mol Clin Oncol, 2021年02月 - Integrity of circulating cell-free DNA as a biomarker for vaccine therapy in patients with non-small cell lung cancer.
Waki K, Yokomizo K, Yoshiyama K, Takamori S, Komatsu N, Yamada A.
Immunopharmacol Immunotoxicol., 2021年02月 - Integrity of plasma cell-free DNA as a prognostic factor for vaccine therapy in patients with endometrial cancer.
Waki K, Yokomizo K, Kawano K, Tsuda N, Komatsu N, Yamada A.
Mol Clin Oncol., 2021年02月 - Plasma level of prostate-related antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines.
Saku S, Toh U, Takao Y, Sakurai S, Yamada A, Shichijo S, Itoh K, Akagi Y.
Exp Ther Med, 2021年 - Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancers. 2020 Aug;111(8):2760-2769.
Toh U, Sakurai S, Saku S, Takao Y, Okabe M, Iwakuma N, Shichijo S, Yamada A, Itoh K, Akagi Y.
Cancer Sci., 2020年08月 - Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients.
Suekane S, Yutani S, Yamada A, Sasada T, Matsueda S, Takamori S, Toh U, Kawano K, Yoshiyama K, Sakamoto S, Sugawara S, Komatsu N, Yamada T, Naito M, Terasaki M, Mine T, Itoh K, Shichijo S, Noguchi M.
Int J Oncol., 2020年06月 - Integrity of plasma DNA is inversely correlated with vaccine-induced anti-tumor immunity in ovarian cancer patients.
Waki K, Yokomizo K, Kawano K, Tsuda N, Komatsu N, Yamada A.
Cancer Immunol Immunother., 2020年05月 - Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial.
Noguchi M, Arai G, Egawa S, Ohyama C, Naito S, Matsumoto K, Uemura H, Nakagawa M, Nasu Y, Eto M, Suekane S, Sasada T, Shichijo S, Yamada A, Kakuma T, Itoh K.
Cancer Immunol Immunother, 2020年02月 - The CD4/CD8 ratio is a prognostic factor in IgG non-responders among peptide vaccine treated ovarian cancer patients.
Waki K, Kawano K, Tsuda N, Komatsu N, Yamada A.
Cancer Sci,, 2020年01月 - Identification of dominant T-cell epitopes in the major Japanese cypress pollen allergen Cha o 3.
Osada T, Yamada A, Sasaki E, Utsugi T.
Allergol Int., 2019年08月 - A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.
Narita Y, Arakawa Y, Yamasaki F, Nishikawa R, Aoki T, Kanamori M, Nagane M, Kumabe T, Hirose Y, Ichikawa T, Kobayashi H, Fujimaki T, Goto H, Takeshima H, Ueba T, Abe H, Tamiya T, Sonoda Y, Natsume A, Kakuma T, Sugita Y, Komatsu N, Yamada A, Sasada T, Matsueda S, Shichijo S, Itoh K, Terasaki M.
Neuro Oncol., 2019年02月 - Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
Osada T, Tanaka Y, Yamada A, Sasaki E, Utsugi T.
Allergol Int., 2018年10月 - Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers.
Noguchi M, Koga N, Moriya F, Suekane S, Yutani S, Yamada A, Shichijo S, Kakuma T, Itoh K.
Cancer Sci., 2018年09月 - Immunological efficacy of herbal medicines in prostate cancer patients treated by personalized peptide vaccine.
Koga N, Moriya F, Waki K, Yamada A, Itoh K, Noguchi M.
Cancer Sci., 2017年12月 - Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.
Sakamoto S, Yamada T, Terazaki Y, Yoshiyama K, Sugawara S, Takamori S, Matsueda S, Shichijo S, Yamada A, Noguchi M, Itoh K, Hattori N, Kohno N, Sasada T.
Clin Lung Cancer, 2017年11月 - Clinical Impact of Tumor-Infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma.
Sudo T, Nishida R, Kawahara A, Saisho K, Mimori K, Yamada A, Mizoguchi A, Kadoya K, Matono S, Mori N, Tanaka T, Akagi Y.
Ann Surg Oncol., 2017年11月 - Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies.
Yutani S, Shirahama T, Muroya D, Matsueda S, Yamaguchi R, Morita M, Shichijo S, Yamada A, Sasada T, Itoh K.
Cancer Sci., 2017年09月 - A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer.
Shirahama T, Muroya D, Matsueda S, Yamada A, Shichijo S, Naito M, Yamashita T, Sakamoto S, Okuda K, Itoh K, Sasada T, Yutani S.
Cancer Sci., 2017年05月 - Immunological evaluation of peptide vaccination for cancer patients with the HLA-A11+ or -A33+ allele.
Sakamoto S, Matsueda S, Takamori S, Toh U, Noguchi M, Yutani S, Yamada A, Shichijo S, Yamada T, Suekane S, Kawano K, Naitou M, Sasada T, Hattori N, Kohno N, Itoh K.
Cancer Sci., 2017年04月 - Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer.
Waki K, Kawano K, Tsuda N, Ushijima K, Itoh K, Yamada A.
J Immunol Res., 2017年 - Single nucleotide polymorphisms of the Haptoglobin gene in non-small cell lung cancer treated with personalized peptide vaccination.
Waki K, Yamada T, Yoshiyama K, Terazaki Y, Sakamoto S, Sugawara S, Takamori S, Itoh K, Yamada A.
Oncol Letter, 2017年 - Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site.
Sakamoto S, Yutani S, Shichijo S, Morita M, Yamada A, Itoh K, Noguchi M.
Cancer Immunol Immunother., 2016年10月 - Identification and gene of new major allergen Cha o 3 from Chamaecyparis obtusa (Japanes Cypress) pollen.
Osada T, Harada T, Asaka N, Kino K, Sasaki E, Okano M, Yamada A, Utsugi T.
J Allergy Clin Immunol., 2016年09月 - A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate Cancer.
Yoshimura K, Minami T, Nozawa M, Kimura T, Egawa S, Fujimoto H, Yamada A, Itoh K, Uemura H.
Eur Urol., 2016年07月 - Randomized phase II study of docetaxel plus personalized peptide vaccination versus docetaxel plus placebo for patients with previously treated advanced wild type EGFR non-small-cell lung cancer.
Takayama K, Sugawara S, Saijo Y, Maemondo M, Sato A, Takamori S, Harada T, Sasada T, Kakuma T, Kishimoto J, Yamada A, Noguchi M, Itoh K, Nakanishi Y.
J Immunol Res., 2016年05月 - Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients.
Iwasa S, Yamada Y, Heike Y, Shoji H, Honma Y, Komatsu N, Matsueda S, Yamada A, Morita M, Yamaguchi R, Tanaka N, Kawahara A, Kage M, Shichijo S, Sasada T, Itoh K.
Cancer Science, 2016年05月 - A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer.
Noguchi M, Moriya F, Koga N, Matsueda S, Sasada T, Yamada A, Kakuma T, Itoh K.
Cancer Immunol Immunother., 2016年02月 - Blockade of High Mobility Group Box 1 (HMGB1) augments anti-tumor T-cell response induced by peptide vaccination as a co-adjuvant.
Waki K, Yamada A.
Cancer Sci., 2016年 - Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer.
Muroya D, Yutani S, Shichijo S, Yamada A, Sakamoto S, Naito M, Okuda K, Morita M, Yamaguchi R, Itoh K.
Evid Based Complement Alternat Med., 2016年 - An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy.
Noguchi M, Matsumoto K, Uemura H, Arai G, Eto M, Naito S, Ohyama C, Nasu Y, Tanaka M, Moriya F, Suekane S, Matsueda S, Komatsu N, Sasada T, Yamada A, Kakuma T, Itoh K.
Clin Cancer Res., 2016年01月 - Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele.
Sakamoto S, Matsueda S, Takamori S, Toh U, Noguchi M, Yutani S, Yamada A, Shichijo S, Yamada T, Suekane S, Kawano K, Sasada T, Hattori N, Kohno N, Itoh K.
Cancer Sci., 2015年10月 - Phase II study of personalized peptide vaccination with both a hepatitis C virus (HCV)-derived peptide and peptides from tumor-associated antigens for the treatment of HCV-positive advanced hepatocellular carcinoma patients.
Yutani S, Ueshima K, Abe K, Ishiguro A, Eguchi J, Matsueda S, Komatsu N, Shichijo S, Yamada A, Itoh K, Sasada T, Kudo M, Noguchi M.
J Immunol Res., 2015年10月 - Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination.
Sakamoto S, Yoshitomi M, Yutani S, Terazaki Y, Yoshiyama K, Ioji T, Matsueda S, Yamada A, Takamori S, Itoh K, Hattori N, Kohno N, Sasada T.
Hum Vaccin Immunother, 2015年09月 - Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy.
Kawano K, Tsuda N, Waki K, Matsueda S, Hata Y, Ushijima K, Itoh K, Yamada A, Kamura T.
Cancer Sci., 2015年09月 - Identification of Novel Lck-derived T Helper Epitope Long Peptides Applicable for HLA-A2+ Cancer Patients as Cancer Vaccine.
Matsueda S, Shichijo S, Nagata S, Seki C, Yamada A, Noguchi M, Itoh K.
Cancer Sci., 2015年08月 - Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression.
Noguchi M, Arai G, Matsumoto K, Naito S, Moriya F, Suekane S, Komatsu N, Matsueda S, Sasada T, Yamada A, Kakuma T, Itoh K.
Cancer Immunol Immunother, 2015年04月 - Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens.
Yamada T, Terazaki Y, Sakamoto S, Yoshiyama K, Matsueda S, Komatsu N, Waki K, Yamada A, Kawahara A, Kage M, Sugawara S, Yamashita Y, Sasada T, Takamori S, Itoh K.
Int J Oncol., 2015年01月 - Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer.
Kibe S, Yutani S, Motoyama S, Nomura T, Tanaka N, Kawahara A, Yamaguchi T, Matsueda S, Komatsu N, Miura M, Hinai Y, Hattori S, Yamada A, Kage M, Itoh K, Akagi Y, Sasada T.
Cancer Immunol Res., 2014年12月 - PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer.
Waki K, Yamada T, Yoshiyama K, Terazaki Y, Sakamoto S, Matsueda S, Komatsu N, Sugawara S, Takamori S, Itoh K, Yamada A.
Cancer Sci., 2014年10月 - Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patients.
Kawano K, Tsuda N, Matsueda S, Sasada T, Watanabe N, Ushijima K, Yamaguchi T, Yokomine M, Itoh K, Yamada A, Kamura T.
Immunopharmacol Immunotoxicol., 2014年06月 - Personalized Peptide Vaccine for Treatment of Advanced Cancer.
Sasada T, Yamada A, Noguchi M, Itoh K.
Curr Med Chem., 2014年02月 - The influence of Chlorella and its hot water extract supplementation on quality of life in patients with breast cancer.
Noguchi N, Maruyama I, Yamada A.
Evid Based Complement Alternat Med., 2014年 - A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time.
Noguchi M, Moriya F, Suekane S, Ohnishi R, Matsueda S, Sasada T, Yamada A, Itoh K.
BMC Cancer., 2013年12月 - A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients.
Yutani S, Komatsu N, Yoshitomi M, Matsueda S, Yonemoto K, Mine T, Noguchi M, Ishihara Y, Yamada A, Itoh K, Sasada T.
Oncol Rep., 2013年09月 - Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: a new biomarker for overall survival of patients with malignant diseases.
Matsueda S; Komatsu N; Kusumoto K; Koga S; Yamada A; Kuromatsu R; Yamada S; Seki R; Yutani S; Shichijo S; Mine T; Fukuda T; Okamura T; Okuda S; Sata M; Honda J; Kaji M; Itoh K; Sasada T
Developmental and comparative immunology, 2013年09月, ［査読有り］ - Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine.
Yutani S, Komatsu N, Matsueda S, Yoshitomi M, Shirahama T, Yamada A, Itoh K, Sasada T.
Evid Based Complement Alternat Med., 2013年06月 - Current status of immunotherapy for the treatment of biliary tract cancer.
Takahashi R, Yoshitomi M, Yutani S, Shirahama T, Noguchi M, Yamada A, Itoh K, Sasada T.
Hum Vaccin Immunother., 2013年05月 - The next generation of peptide vaccines for advanced cancer.
Yamada A, Sasada T, Noguchi M, Itoh K.
Cancer Sci, 2013年01月 - Controversies in Clinical Trials of Cancer Vaccines for Glioblastoma.
Terasaki1 M, Murotani K, Narita Y, Nishikawa R, Sasada T, Yamada A, Itoh K, Morioka M.
J Vaccines Vaccin., 2013年 - In vitro induction of specific CD8+ T lymphocytes by tumor-associated antigenic peptides in patients with oral squamous cell carcinoma.
Toyoshima T, Kumamaru W, Hayashida J, Moriyama M, Kitamura R, Tanaka H, Yamada A, Itoh K, Nakamura S.
Cancer Lett, 2012年09月, ［査読有り］ - Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination.
Komatsu N, Matsueda S, Tashiro K, Ioji T, Shichijo S, Noguchi M, Yamada A, Doi A, Suekane S, Moriya F, Matsuoka K, Kuhara S, Itoh K, Sasada T.
Cancer, 2012年06月15日, ［査読有り］ - Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy.
Noguchi M, Moriya F, Suekane S, Matsuoka K, Arai G, Matsueda S, Sasada T, Yamada A, Itoh K.
Prostate, 2012年06月01日, ［査読有り］ - Personalized peptide vaccination in patients with refractory non-small cell lung cancer.
Yoshiyama K, Terazaki Y, Matsueda S, Shichijo S, Noguchi M, Yamada A, Mine T, Ioji T, Itoh K, Shirouzu K, Sasada T, Takamori S.
Int J Oncol, 2012年05月, ［査読有り］ - Immunological Evaluation of Personalized Peptide Vaccination in Refractory Small Cell Lung Cancer.
Terazaki Y, Yoshiyama K, Matsueda S, Watanabe N, Kawahara A, Naito Y, Suekane S, Komatsu N, Ioji T, Yamada A, Mine T, Terasaki M, Itoh K, Takamori S, Sasada T.
Cancer Sci., 2012年04月 - Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status, and pre-existing antigen -specific immunity as possible biomarkers for patient prognosis.
Yoshitomi M, Yutani S, Matsueda S, Ioji T, Komatsu N, Shichijo S, Yamada A, Itoh K, Sasada T, Kinoshita H.
Experimental and Therapeutic Medicine, 2012年03月, ［査読有り］ - A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer.
Noguchi M, Uemura H, Naito S, Akaza H, Yamada A, Itoh K.
Prostate., 2011年04月 - Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination.
Noguchi M, Mine T, Komatsu N, Suekane S, Moriya F, Matsuoka K, Yutani S, Shichijo S, Yamada A, Toh U, Kawano K, Azuma K, Uemura H, Okuno K, Matsumoto K, Yanagimoto H, Yamanaka R, Oka M, Todo S, Sasada T, Itoh K.
Cancer Biol Ther., 2011年01月 - Phase I trial of a personalized Peptide vaccine for patients positive for human leukocyte antigen--A24 with recurrent or progressive glioblastoma multiforme.
Terasaki M, Shibui S, Narita Y, Fujimaki T, Aoki T, Kajiwara K, Sawamura Y, Kurisu K, Mineta T, Yamada A, Itoh K.
J Clin Oncol., 2011年01月 - Characteristics of severe adverse events after peptide vaccination for advanced cancer patients: analysis of 500 cases.
Yoshida K, Noguchi M, Mine T, Komatsu N, Yutani S, Ueno T, Yanagimoto H, Kawano K, Itoh K, Yamada A.
Oncol Report., 2011年01月 - Phase-I clinical study of a personalized peptide vaccination available for six different HLA (HLA-A2, -A3, -A11, -A24, -A31, and -A33)-positive patients with advanced cancer.
Yamada A, Noguchi M, Komatsu N, Suekane S, Yutani S, Moriya F, Mine T, Momozono K, Kawano K, Itoh K.
Exp Ther Med., 2011年01月, ［査読有り］ - A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin.
Matsumoto K, Noguchi M, Satoh T, Tabata KI, Fujita T, Iwamura M, Yamada A, Komatsu N, Baba S, Itoh K.
BJU Int., 2010年12月 - A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients.
Yanagimoto H, Shiomi H, Satoi S, Mine T, Toyokawa H, Yamamoto T, Tani T, Yamada A, Kwon A, Komatsu N, Itoh K, Noguchi M.
Oncol Rep., 2010年09月 - Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines.
Sasada T, Komatsu N, Suekane S, Yamada A, Noguchi M, Itoh K.
Eur J Cancer, 2010年07月 - A randomized phase II trial of personalized peptide vaccine plus low dose estramustine (EMP) versus standard dose EMP in patients with hormone refractory prostate cancer.
Noguchi M, Kakuma T, Uemura H, Nasu Y, Kumon H, Moriya F, Suekane S, Komatsu N, Yamada A, Itoh K.
Cancer Immunol. Immunother., 2010年07月 - Prophylactic effect of peptide vaccination against hepatocellular carcinoma associated with hepatitis C virus
Nobukazu Komatsu; Shigeru Yutani; Akira Yamada; Shigeki Shichijo; Kazumi Yoshida; Minoru Itou; Ryoko Kuromatsu; Tatsuya Ide; Masatoshi Tanaka; Michio Sata; Kyogo Itoh
Experimental and Therapeutic Medicine, 2010年07月, ［査読有り］ - Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines.
Sasada T, Komatsu N, Suekane S, Yamada A, Noguchi M, Itoh K.
Eur J Cancer., 2010年06月 - Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination.
Iseki K, Matsunaga H, Komatsu N, Suekane S, Noguchi M, Itoh K, Yamada A.
Cancer Sci., 2010年, ［査読有り］ - Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients.
Hattori T, Mine T, Komatu N, Yamada A, Itoh K, Shiozaki H, Okuno K.
Cancer Immunol. Immunother., 2009年11月 - Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different HLA-class I-A alleles.
Yutani S, Komatsu N, Shichijo S, Yoshida K, Takedatsu H, Itou M, Kuromatu R, Ide T, Tanaka M, Sata M, Yamada A, and Itoh K.
Cancer Science., 2009年10月, ［査読有り］ - A peptide derived from hepatitis C virus (HCV) core protein inducing cellular responses in patients infected with HCV with various HLA class IA allele.
Niu Y, Komatsu N, Komohara Y, Matsueda S, Yutani S, Ishihara Y, Itou M, Yamada A, Itoh K, Shichijo S.
J. Med. Virol., 2009年07月 - Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Azuma K, Sasada T, Kawahara A, Takamori S, Hattori S, Ikeda J, Itoh K, Yamada A, Kage M, Kuwano M, Aizawa H.
Lung Cancer., 2009年06月 - Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients.
Naito M, Itoh K, Komatsu N, Yamashita Y, Shirakusa T, Yamada A, Moriya F, Ayatuka H, Mohamed ER, Matsuoka K, Noguchi M.
Prostate, 2008年12月01日, ［査読有り］ - Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2(+) glioma patients
Mingyue Jin; Yoshihiro Komohara; Shigeki Shichijo; Ryuya Yamanaka; Junichi Nikawa; Kyogo Itoh; Akira Yamada
CANCER SCIENCE, 2008年08月, ［査読有り］ - A randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms.
Noguchi M, Kakuma T, Tomiyasu K, Yamada A, Itoh K, Konishi F, Kumamoto S, Shimizu K, Kondo R, Matsuoka K.
Asian J. Androl., 2008年 - EphB6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in HLA-A2+ glioma patients.
Jin M, Komohara Y, Shichijo S, Nikawa J, Yamanaka R, Itoh K, Yamada A.
Cancer Sci., 2008年 - Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24+ malignant glioma patients.
Jin M, Komohara Y, Shichijo S, Harada M, Yamanaka R, Miyamoto S, Nikawa J, Itoh K, Yamada A.
Oncol. Report, 2008年 - Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer.
Yanagimoto Y., Takai S., Yamamoto K., Mine T., Satoi S., Takahashi K., Terakawa N., Yamada A, Itoh K., Kamiyama S
Caner Science, 2007年 - Serum levels of IgG to the peptide of HCV-1b core at positions 35-44 correlated with persistent infection, while levels f IgG to the peptide of NS5A at position 2132-2140 correlated with better prognosis in HCV-infected patients.
Takao Y, Yutani S, Ono T, Takedatsu H, Hiraga S, Nagao Y, Ando E, Yamada A, Itoh K, Sata M.
Medical Microbiol. Immunol., 2007年 - HLA-G as a target molecule in specific immunotherapy against renal cell carcinoma.
Komohara Y, Harada M, Ishihara Y, Suekane S, Noguchi M, Yamada A, Matsuoka K, Itoh K.
Oncol Report, 2007年 - Identification of target antigens in specific immunotherapy for renal cell carcinoma.
Komohara Y, Harada M, Arima Y, Suekane S, Noguchi M, Yamada A, Itoh K, Matsuoka K.
J Urol., 2007年 - Phase 1 clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy.
Yutani S, Yamada A, Yoshida K, Takao Y, Tamura M, Komatsu N, Ide T, Tanaka M, Sata M, and Itoh K.
Vaccine, 2007年 - Excision Repair Cross-Complementation Group 1 Predicts Progression-Free and Overall Survival in Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.
Azuma K, Komohara Y, Sasada T, TerazakiY, Ikeda J, Hoshino T, Itoh K, Yamada A, Aizawa H.
Cancer Science, 2007年 - Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles.
Naito M, Komohara Y, Ishihara Y, Noguchi M, Yamashita Y, Shirakusa T, Yamada A, Itoh K,and Harada M.
Br. J. Cancer, 2007年 - Immunological evaluation of personalized peptide vaccination in combination with a 5-fluorouracil derivative (TS-1) for advanced gastric or colorectal carcinoma patients.
Sato Y, Fujiwara T, Mine T, Shomura H, Honma S, Maeda Y, Tokunaga N, Ikeda Y, Ishihara Y, Yamada A, Tanaka N, Itoh K, Harada M, Todo S.
Cancer Science, 2007年 - Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: An analysis of prognostic factors in the treatment.
Noguchi M, Mine T, Yamada A, Obata Y, Yoshida K, Mizoguchi J, Harada M, Suekane S, Itoh K, Matsuoka K.
Oncology Research, 2007年 - Expression of APOBEC3G in kidney cells.
Y Komohara, S Suekane, M Noguchi, K Matsuoka, A Yamada, K Itoh.
Tissue Antigen, 2007年 - Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b that can induce both cellular and humoral immunity in HCV1b+ HLA-A24+ patients.
Takao Y, Yamada A, Yutani S, Takedatsu H, Ono T, Etoh K, Ide T, Simotohno K, Sata M, Itoh K.
Hepatol. Res, 2007年 - Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b that can induce both cellular and humoral immunity in HCV1b+ HLA-A24+ patients.
Takao Y, Yamada A, Yutani S, Takedatsu H, Ono T, Etoh K, Ide T, Simotohno K, Sata M, Itoh K.
Hepatol. Res., 2007年 - A new epitope peptide derived from hepatitis C virus (HCV) 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31 and -A33.
S Matsueda, A Yamada, Y Takao, M Tamura, N Komatsu , S Yutani, T Ide, M Sata, and K Itoh.
Cancer Immunol. Immunother., 2007年 - A Phase I Trial of Personalized Peptide Vaccination for Cytokine-refractory Metastatic Renal Cell Carcinoma Patients.
Suekane S, Nishitani M, Noguchi M, Komohara Y, Kokubu T, Naitoh M, Honma S, Yamada A, Itoh K, Matuoka K, Kanayama H.
Cancer Sci., 2007年 - Prostate-specific antigen-reactive cytotoxic T lymphocyte precursors in colon cancer patients.
Wang Y, Harada M, Yano H, Ogasawara S, Tanaka M, Yamada A, Itoh K.
Oncol Rep., 2006年02月, ［査読有り］ - High expression of APOBEC3G in patients infected with hepatitis C virus.
Komohara Y, Yano H, Shichijo S, Shimotohno K, Itoh K, Yamada A.
J Mol Histol., 2006年 - Personalized peptide vaccines: A new therapeutic modality for cancer.
Itoh K, Yamada A.
Cancer Sci., 2006年 - Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinoma.
Komohara Y, Harada M, Arima Y, Suekane S, Noguchi M, Yamada A, Itoh K, Matsuoka K.
Int J Oncol., 2006年 - New epitope peptides derived from hepatitis C virus(HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.
Wang Y, Takao Y, Harada M, Yutani S, Ide T, Sata M, Itoh K, Yamada A.
Microbiol Immunol., 2006年 - Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
Wang Y, Takao Y, Harada M, Komatsu N, Ono T, Sata M, Yamada A, Itoh K.
Cell Immunol., 2006年 - Anti-tumor effects of systemic and local immunization with a cytotoxic T lymphocyte-directed peptide in combination with a local injection of OK-432.
Ono T, Harada M, Yamada A, Tanaka M, Takao Y, Tanaka Y, Mine T, Sakamoto K, Nakashima T, Itoh K.
Clin Cancer Res., 2006年 - Nonmutated Self-Antigen-Derived Cancer Vaccine Peptides Elicit an IgE-Independent but Mast Cell-Dependent Immediate-Type Skin Reaction without Systemic Anaphylaxis.
Yamada A, Yano H, Takao Y, Ono T, Matsumoto T, Itoh K.
J Immunol., 2006年01月, ［査読有り］ - Immunological and clinical evaluation of personalized peptide vaccination for Patients with advanced malignant glioma.
Yajima N, Yamanaka R, Mine T, Tsuchiya N, Honma J, Sano M, Kuramoto T, Obata Y, Komatsu N, Arima Y, Yamada A, Shigemori M, Itoh K, Tanaka R.
Clin Cancer Res., 2005年08月, ［査読有り］ - Immunological evaluation of personalized peptide vaccination for patients with pancreatic cancer.
Yamamoto K, Mine T, Katagiri K, Suzuki N, Kawaoka T, Ueno T, Matsueda S, Yamada A, Itoh K, Yamana H, Oka M.
Oncol Rep., 2005年05月, ［査読有り］ - Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24(+) HRPC patients.
Noguchi M, Itoh K, Yao A, Mine T, Yamada A, Obata Y, Furuta M, Harada M, Suekane S, Matsuoka K.
Prostate., 2005年 - Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b+ HLA-A24+ patients.
Tamura M, Yamada A, Takao Y, Matsueda S, Komatsu N, Yutani S, Ibe T, Sata M, Itoh K.
Hepatol Res., 2005年 - Prostatic acid phosphatase as a target molecule in specific immunotherapy for patients with non-prostate adenocarcinoma.
Wang Y, Harada M, Yano H, Ogasawara S, Takedatsu H, Arima Y, Matsueda S, Yamada A, Itoh K.
J Immunother., 2005年 - Immunological evaluation of vaccination of peptides derived from epithelial cancer-related antigens in two patients with hematological malignancy.
Takedatsu H, Yoshimoto K, Okamura T, Yakushij K, Imamura R, Hashiguchi M, Seki R, Obata Y, Harada M, Yamada A, Yamana H, Sata M, Itoh K.
Int J Oncol., 2005年 - Analysis of cellular localization of SART3 tumor antigen by newly established monoclonal antibody: Heterotopic expression of SART3 tumor antigen on the surface of B-lineage leukemic cells.
M. Koga, N. Komatsu, S. Shichijo, K. Itoh, and A. Yamada.
Oncol. Reports, 2004年04月, ［査読有り］ - Phase I trial of patient-oriented vaccination in HLA-A2 positive patients with metastatic hormone refractory prostate cancer.
Noguchi M, Itoh K, Suekane S, Yao A, Suetsugu N, Katagiri K, Yamada A, Yamana H, Noda S.
Cancer Sci., 2004年 - Immunological monitoring during combination of patient-oriented peptide vaccination and estramustin phosphate I patients with metastatic hormone refractory prostate cancer.
M. Noguchi, K. Itoh, S. Suekane, A. Morinaga, A. Sukehiro, N. Suetsugu, K. Katagiri, A. Yamada, and S. Noda.
Prostate, 2004年 - Immunological evaluation of pre-designated vaccination of the peptides frequently vaccinated to cancer patients in an individualized peptide regimen.
Mochizuki K, Sato Y, Tsuda N, Shomura H, Sakamoto M, Matsuura K, Ushijima K, Maeda Y, Katagiri K, Yamada A, Todo S, Kamura T, Itoh K.
Int. J. Oncol., 2004年 - Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of inducing HLA-A2 rstricted cytotoxic T lymphocytes is detectable in the majority of HCV-infected individuals without HLA-A2 restriction.
Takao Y, Yamada A, Yutani S, Sata M, Itoh K.
Microbiol. Immunol., 2004年 - Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides besed on pre-existing peptide-specific cellular responses.
T. Mine, Y. Sato, M. Noguchi, T. Sasatomi, R. Gouhara, N. Tsuda, S. Tanaka, H. Shomura, K. Katagiri, T. Rikimaru, S. Shichijo, T. Kamura, T. Hashimoto, K. Shirouze, A. Yamada, S. Todo, K. Itoh, and H. Yamana.
Clin. Cancer Res., 2004年 - A phase I trial of CTL-purecursor-oriented peptide vaccine for colorectal carcinoma patients.
Y. Sato, Y. Maeda, T. Sasatomi, M. Takahashi, Y. Une, M. Kondo, T. Shinohara, N. Hida, K. Katagiri, K. Sato, A. Yamada, H. Yamana, K. Itoh, and S. Todo.
Br. J. Cancer, 2004年 - Natural antibodies reactive to self peptides which had been identified as cytotoxic T-lymphocyte (CTL)-directed tumor antigens.
Fukuda K, Takao Y, Miyazaki Y, Itoh K, Yamada A.
Immunobiology., 2004年 - Vaccination with pre-designated or evidence-based peptides for patients with recurrent gynecologic cancers.
N. Tsuda, K. Mochizuki, M. Harada, A. Sukehiro, K. Kawano, A. Yamada, K. Ushijima, T. Sugiyama, T. Nishida, H. Yamana, K. Itoh, and T. Kamura.
J. Immunother., 2004年01月, ［査読有り］ - Identification of cytotoxic T lymphocyte-directed epitope encoded by an intron of putative tumor suppresser gene Testin of the common fragile site 7G region at 7q31.2: Peptide vaccine candidate for HLA-B52+ and -62+ cancer patients.
S. Ohkouchi, N. Kawamoto , F. Sakanashi, S. Shichijo, Y. Saijo, T. Nukiwa, K. Itoh, and A. Yamada.
Eur. J. Immunol., 2003年11月, ［査読有り］ - Peptide vaccination for patients with melanoma and other types of cancers based on pre-existing peptide-specific cytotoxic T lymphocyte precursors in the periphery.
S. Tanaka, M. Harada, T. Mine, M. Noguchi, R. Gohara, K. Azuma, M. Tamura, A. Yamada, A. Morinaga, M. Nishikori, K. Katagiri, K. Itoh, H. Yamana, and T. Hashimoto.
J. Immunother., 2003年07月, ［査読有り］ - Depolymerization of actin filament by cytochalasin E induces interleukin-8 production and up-regulates CD54 in the Hela epithelial cell line.
N. Ikewaki, A. Yamada, and H. Inoko.
Microbiol. Immunol., 2003年 - Induction fo cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination.
M. Noguchi, K. Kobayashi, N. Suetsugu, K. Tomiyasu, S. Suekane, A. Yamada, K. Itoh, and S. Noda.
Prostate, 2003年 - Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide.
Y. Sato, H. Shomura, Y. Maeda, T. Mine, Y. Une, Y. Akasaka, M. Kondo, S. Takahashi, T. Shinohara, K. Katagiri, M. Sato, S. Okada, K. Matsui, A. Yamada, H. Yamana, K. Itoh, and S. Todo.
Cancer Sci., 2003年 - IgG reactive to CTL-directed epitope peptides is either lacking or unbalanced in atopic dermatitis patients.
N. Kawamoto, S. Ohkouchi, T. Maeda, S. Tanaka, T. Hashimoto, S. Saijo, Y. Saijo, S. Shichijo, K. Itoh, and A. Yamada
Tissue Antigens, 2003年 - Cellular and humoral immune responses to tumor cells and peptides in lung cancer patients vaccinated with cyclophilinB peptide.
R. Gohara, N. Imai, T. Rikimaru, A. Yamada, M. Ichiki, M. Kawamoto, K. Matsunaga, J. Ashihara, S. Yano, S. Ohkouchi, H. Yamana, K. Oizumi, and K. Itoh.
J. Immunother., 2002年 - Expression of MAGE-1 and -4 proteins in normal tissues and various cancers
K Itoh; Y Imai; T Kuramoto; A Yamada; H Yamana; S Shichijo
MELANOGENESIS AND MALIGNANT MELANOMA: BIOCHEMISTRY, CELL BIOLOGY, MOLECULAR BIOLOGY, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, 1996年, ［査読有り］ - Antigen-specific augmentation factor involved in murine delayed-type hypersensitivity
I. Kawamura; K. Himeno; M. Sakumoto; A. Yamada; K. Nomoto
International Journal of Immunopharmacology, 1988年, ［査読有り］
- がん免疫療法 臨床研究から学ぶヒト腫瘍免疫学 CTLエピトープワクチン療法(Cancer Immunotherapy: Bedside to Bench Recent advances of cancer vaccines with CTL epitope peptides)
伊東 恭悟; 山田 亮; 植村 天受; 笹田 哲朗; 野口 正典
日本癌学会総会記事, 2013年10月 - Personalized peptide vaccination: a novel immunotherapeutic approach for advanced cancer.
Sasada T, Noguchi M, Yamada A, Itoh K.
Hum Vaccin Immunother., 2012年09月 - Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination
M. Noguchi; T. Mine; N. Komatsu; S. Suekane; F. Moriya; K. Yoshida; S. Yutani; S. Shichijo; A. Yamada; K. Itoh
JOURNAL OF CLINICAL ONCOLOGY, 2010年05月 - Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer.
Hirotsugu Uemura; Kiyohide Fujimoto; Takashi Mine; Shigeya Uejima; Marco A de Velasco; Yoshihiko Hirao; Nobukazu Komatsu; Akira Yamada; Kyogo Itoh
Cancer science, 2010年03月 - Recent advances in cancer vaccines: an overview.
Itoh K, Yamada A, Mine T, Noguchi M.
Jpn J Clin Oncol., 2009年 - 口腔扁平上皮癌患者における腫瘍周囲のリンパ球浸潤と抗腫瘍細胞傷害性T細胞のin vitro誘導との関連
豊嶋 健史; 中村 誠司; 熊丸 渉; 石橋 浩晃; 大山 順子; 嘉手納 勉; 佐々木 匡理; 川村 英司; 林田 淳之將; 森山 雅文; 山田 亮; 伊東 恭悟; 白砂 兼光
日本癌学会総会記事, 2004年09月 - Cellular and humoral immune response to recurrent colorectal cancer by peptide vaccination with chemotherapy
T Sasatomi; K Azuma; A Morinaga; Y Miyagi; N Imai; K Katagiri; Y Ogata; A Yasumi; A Yamada; H Yamana; K Itoh; K Shirouzu
DISEASES OF THE COLON & RECTUM, 2004年06月 - T cell receptor Vb gene usage by T cells reactive with the tumor rejection antigen SART-1 in oral squamous cell carcinoma.
W. Kumamaru, S. Nakamura, T. Kadena, A. Yamada, E. Kawamura, M. Sasaki, Y. Ohyama, T. Toyoshima, J. Hayashida, K. Itoh, and K. Shirasuna.
Int. J. Cancer, 2004年02月 - Gene and peptide analyses of newly defined lung cancer rejection antigens recognized by HLA-A2402-restricted tumor-specific cytotoxic T lymphocytes.
A. Yamada, K. Kawano, M. Koga, S. Takamori, M. Nakagawa, and K. Itoh.
Cancer Res., 2003年06月 - Identification of ribosomal proteins S2 and L10a as tumor-rejection antigens recognized by HLA-A26-restricted CTL.
M. Koga, S. Shichijo, A. Yamada, J. Ashihara, H. Sawamizu, J. Kusukawa, and K. Itoh.
Tissue Antigens, 2003年02月 - Identification of ribosomal proteins S2 and L10a as tumor antigens recognized by HLA-A26-restricted CTL
M. Koga; Shigeki Shichijo; A. Yamada; J. Ashihara; H. Sawamizu; J. Kusukawa; K. Itoh
Tissue Antigens, 2003年02月01日 - Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients.
Takashi Mine; Rumi Gouhara; Naoya Hida; Nobue Imai; Kouichi Azuma; Touru Rikimaru; Kazuko Katagiri; Misa Nishikori; Aki Sukehiro; Msami Nakagawa; Akira Yamada; Hisamichi Aizawa; Kazuo Shirouzu; Kyogo Itoh; Hideaki Yamana
Cancer Science, 2003年 - M. Noguchi, K. Kobayashi, N. Suetsugu, K. Tomiyasu, S. Suekane, A. Yamada, K. Itoh, and S. Noda. Induction fo cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide v・・・
2003年 - N. Tsuda, Y. Nonaka, S. Shichijo, A. Yamada, M.Ito, Y. Maeda, M. Harada, T. Kamura, K. Itoh. UDP-Gal: bGlcNAc b1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumor antigen recognized by HLA-A2-restricted cytotoxic T lymphocytes from patients wi・・・
N. Tsuda, Y. Nonaka, S. Shichijo, A. Yamada, M.Ito, Y. Maeda, M. Harada, T. Kamura, K. Itoh.
Br. J. Cancer, 2002年10月 - Simple assay for antitumor immuno-active glycoprotein derived from Chlorella vulgaris strain CK22 using ELISA
K. Noda, K. Tanaka, A. Yamada, J. Ogata, H. Tanaka, and Y. Shoyama.
Phytother. Res., 2002年09月 - Non-mutated tumor-rejection antigen peptides elicit type-I allergy in the majority of healthy individuals.
S. Ohkouchi, A. Yamada, N. Imai, T. Mine, K. Harada, S. Shichijo, Y. Maeda, Y. Saijo, T. Nukiwa, and K. Itoh.
Tissue Antigens, 2002年04月 - R. Gohara, N. Imai, T. Rikimaru, A. Yamada, M. Ichiki, M. Kawamoto, K. Matsunaga, J. Ashihara, S. Yano, S. Ohkouchi, H. Yamana, K. Oizumi, and K. Itoh. Cellular and humoral immune responses to tumor cells and peptides in lung cancer patients vaccinated・・・
2002年 - M. Tsuru, K. Nagata, T. Ueno, A. Jimi, K. Irie, A. Yamada, R. Nagai, S. Horiuchi, and M. Sata. Effect of AGEs on Human Disc Herniation; Intervertebral Disc Hernia is also Cursed by AGEs
Kuume Med. J, 2002年 - R. Gohara, N. Imai, T. Rikimaru, A. Yamada, M. Ichiki, M. Kawamoto, K. Matsunaga, J. Ashihara, S. Yano, S. Ohkochi, H. Yamana, K. Oizumi,and K, Itoh. Cellular and Humoral Immune Responses to Tumor Cells and Peptides in lung Cancer Patients Vaccinated w・・・
J. Immunother, 2002年 - Induction of cellular immune responses to tumor cells and peptides in colorectal cancer patients by vaccination of SART3 peptides
Y. Miyagi, N. Imai, T. Sasatomi, A. Yamada, T. Mine, K. Katagiri, M. Nakagawa, A. Muto, S. Okouchi, H. Isamoto, K. Shirouzu, H. Yamana, and K. Itoh.
Clin. Cancer Res., 2001年12月 - Electron microscopic observation of established chondrocytes derived from human intervertebral disc hernia (KTN-1) and role of macrophages in spontaneous regression of degenerated tissues
Michiyo Tsuru; Kensei Nagata; Takato Ueno; Atsuo Jimi; Kouji Irie; Akira Yamada; Toshiharu Nishida; Michio Sata
Spine Journal, 2001年11月12日 - dentification of Lck-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with distant metastases.
N. Imai, N. Harashima, M. Ito, Y. Miyagi, M. Harada, A. Yamada, and K. Itoh.
Int. J. Cancer, 2001年10月 - Multidrug resistance-associated protein 3 is a tumor rejection antigen recognized by HLA-A2402-restricted cytotoxic T lymphocytes
A Yamada; K Kawano; M Koga; T Matsumoto; K Itoh
CANCER RESEARCH, 2001年09月 - Multidrug resistance-associated protein 3 (MRP3) is a tumor rejection antigen recognized by HLA-A2402-restricted cytotoxic T lymphocytes.
A. Yamada, K. Kawano, M. Koga, T. Matsumoto, and K. Itoh.
Cancer Res., 2001年09月 - Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS1: a possible regulation of splicing by the complex formation.
K. Harada, A. Yamada, D. Yang, K. Itoh, and S. Shichijo.
Int. J. Cancer, 2001年09月 - Expression of a newly defined tumor-rejection antigen SART3 in musculoskeletal tumors and induction of HLA class I-restricted cytotoxic T lymphocytes by SART3-derived peptides.
N. Tsuda, K. Murayama, H. Ishida, K. Matsunaga, S. Komiya, K. Itoh, and A. Yamada
J. Orthopaed. Res., 2001年05月 - Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of metastatic cancer patients.
N. Harashima, K. Tanaka, , T. Sasadomi, K. Shimizu, Y. Miyagi, A. Yamada, M. Tamura, H. Yamana, K. Itoh, and S. Shichijo.
Eur. J. Immunol., 2001年02月 - Chlorella vulgaris supernatant (CVS) reduces psychological stress-induced apoptosis in thymocytes of mice.
T. Hasegawa, K. Noda, S. Kumamoto, Y. Ando, A. Yamada, and Y. Yoshikai.
Int. J. Immunopharmacol, 2000年11月 - A microfilament formation inhibitor, cytochalasin, strongly enhances the low affinity Fc-e receptor II (CD23) expression on the human monocyte-like cell line, U937.
N. Ikewaki, H. Tamauchi, A. Yamada, M. Aoki , R. Yamamoto , A. Sawada and H. Inoko
J. Clin. Immunol., 2000年11月 - Tacrolimus (FK506) treatment of CD34+ hematopoietic progenitor cells promote the development of dendritic cells that drive CD4+ T cells
K. Shimizu, S. Fujii, K. Fujimoto, K. Kawa, A. Yamada, and F. Kawano.
J. Leukocyte Biol., 2000年11月 - Identification of SART3-derived peptides capable of inducing HLA-A2-
M. Ito, S. Shichijo, Y. Miyagi, T. Kobayashi, N. Tsuda, A. Yamada, N. Saito, and K. Ito
Int. J. Cancer., 2000年11月 - Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer
K Kawano; S Gomi; K Tanaka; N Tsuda; T Kamura; K Itoh; A Yamada
CANCER RESEARCH, 2000年07月 - Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor infiltrating lymphocytes of lung cancer.
K. Kawano, S. Gomi, K. Tanaka, T. Kamura, K. Itoh, and A. Yamada
Cancer Res., 2000年07月 - A unique monoclonal antibody mNI-11 rapidly enhances spread
N. Ikewaki, H. Tamauchi, A. Yamada, N. Mori, Y. Fukumoto, R. Shibata, H. Yamao, H. Inoue, and H. Inoko.
J. Clin. Immunol., 2000年07月 - CDw108 expression during T-cell development
T. Mine, K. Harada, T. Matsumoto, H. Yamana, K. Shirouzu, K. Itoh, and A. Yamada
Tissue Antigens., 2000年05月 - Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the cytotoxic T lymphocytes.
M. Nakao, S. Shichijo, T. Imaizumi, Y. Inoue, K. Matsunaga, A. Yamada,
J. Immunol., 2000年03月 - Serum MAGE-4 protein in ovarian cancer patients.
H.Kawagoe, A. Yamada, H. Matsumoto, M. Itoh, K. Ushijima, T. Nishida, and K. Itoh
Gynecologic Oncol., 2000年03月 - Establishment and epitope analysis of allo-specific cytotoxic T lymphocytes at a tumor site recognizing a spouse's HLA-A0206 molecule.
N. Seki, A. Yamada, Y. Suefuji, T. Mine, S. Tanaka, S. Gomi, N. Kawagoe, K. Koufuji, and K. Itoh.
Am. J. Reprod. Immunol., 2000年03月 - Mouse homologue of human SART3 gene encoding tumor rejection antigen.
K. Harada, A. Yamada, T. Mine, N. Kawagoe, H. Takasu, and K. Itoh.
Jap. J. Cancer Res., 2000年02月 - CDw108 expression during T-cell development
T. Mine; K. Harada; T. Matsumoto; H. Yamana; K. Shirouzu; K. Itoh; Akira Yamada
Tissue Antigens, 2000年 - Polymorphism of the 5’-flanking region of the tumor necrosis factor (TNF)-a gene and susceptibility to human T-cell lymphotoropic virus type I (HTLV-1) uveitis.
N. Seki, K. Yamaguchi, A. Yamada, S. Kamizono, S. Sugita, C. Taguchi,
J. Infect. Dis., 1999年09月 - Polymorphisms in the the 5’-flanking region of the tumor necrosis factor-a
N. Seki, S. Kamizono, A. Yamada, T. Higuchi, H. Matsumoto, F. Niiya, A. Kimura, K. Tsuchiya, R. Suzuki, Y. Date, T. Tomita, K. Itoh, and T. Ochi.
Tissue Antigens., 1999年08月 - Analysis of tumor necrosis factor-a production and polymorphisms of
K. Kamizono, A. Yamada, T. Higuchi, H. Kato, and K. Itoh.
Pediatrics Int., 1999年08月 - A. Yamada, K. Kawano, N. Harashima, F. Niiya, K. Nagai, T. Kobayashi, T. Mine, K. Ushijima, T. Nishida, and K. Itoh. Study of HLA-class I-restriction and directed antigens of cytotoxic T lymphocytes at the tumor sites of ovarian cancer. Cancer Immunol.・・・
A. Yamada, K. Kawano, N. Harashima, F. Niiya, K. Nagai, T. Kobayashi, T. Mine, K. Ushijima, T. Nishida, and K. Itoh.
Cancer Immunol. Immunotherapy., 1999年05月 - Study of HLA class I restriction and the directed antigens of cytotoxic T lymphocytes at the tumor sites of ovarian cancer
A Yamada; K Kawano; N Harashima; F Niiya; K Nagai; T Kobayashi; T Mine; K Ushijima; T Nishida; K Itoh
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999年05月 - Oral administration of hot water extracts of Chlorella vulgaris reduces IgE production against milk casein in mice.
T. Hasegawa, K. Ito, S. Ueno, S. Kumamoto, Y. Ando, A. Yamada, K. Nomoto, and Y. Yoshikai.
Int. J. Immunopharmacol., 1999年05月 - Molecular cloning of a glycosylphosphatidylinositol-anchored molecule CDw108.
A. Yamada, K. Kubo, T. Takeshita, N. Harashima, K. Kawano, T. Mine, K. Sagawa, K. Sugamura, and K. Itoh.
J. Immunol., 1999年04月 - A. Yamada, K. Kubo, T. Takeshita, N. Harashima, K. Kawano, T. Mine, K. Sagawa, K. Sugamura, and K. Itoh. Molecular cloning of a glycosylphosphatidylinositol-anchored molecule CDw108. J. Immunol. 162: 4094-4100, 1999."
1999年 - Polymorphism of the 5 '-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese
T Higuchi; N Seki; S Kamizono; A Yamada; A Kimura; H Kato; K Itoh
TISSUE ANTIGENS, 1998年06月 - A novel glycoprotein obtained from Chlorella vulgaris strain CK22 shows antimetastatic immunopotentiation
K Tanaka; A Yamada; K Noda; T Hasegawa; M Okuda; Y Shoyama; K Nomoto
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998年02月 - Oral administration of a unicellular green algae, Chlorealla vulgaris, prevents stress-induced ulcer
K Tanaka; A Yamada; K Noda; Y Shoyama; C Kubo; K Nomoto
PLANTA MEDICA, 1997年10月 - HLA-A2402-restricted and tumor-specific cytotoxic T lymphocytes from tumor-infiltrating lymphocytes of a child with Wilms' tumor
K Nagai; A Yamada; H Eguchi; H Kato; K Itoh
PEDIATRIC RESEARCH, 1997年07月 - A.Yamada, A. Hara, M. Inoue, S. Kamizono, T. Higuchi, and K. Itoh. Β2 integrin-mediated signal up-regulates counter receptor ICAM-1 expression on human monocytic cell line THP-1 through tyrosine phosphorylation. Cell. Immunol., 178: 9-16, 1997."
A Yamada; A Hara; M Inoue; S Kamizono; T Higuchi; K Itoh
CELLULAR IMMUNOLOGY, 1997年05月 - K. Itoh, A. Hayashi, M. Nakao, Y. Imai, A. Yamada, T. Nishida, and S. Scichijo. Development of Cancer Vaccine by Tumor Rejection Antigens
Int. Rev. Immunol, 1997年 - Effect of hot water extract of Chlorella vulgaris on cytokine expression patterns in mice with murine acquired immunodeficiency syndrome after infection with Listeria monocytogenes
T Hasegawa; Y Kimura; K Hiromatsu; N Kobayashi; A Yamada; M Makino; M Okuda; T Sano; K Nomoto; Y Yoshikai
IMMUNOPHARMACOLOGY, 1997年01月 - β2 integrin-mediated signal up-regulates counter receptor ICAM-1 expression on human monocytic cell line THP-1 Cell. Immunol
1997年 - Effect of hot water extract of Chlorella vulgaris on cytokine expression patterns in mice with murine acquired immunodeficiency syndrome after infection with Listeria monocytogenes
T Hasegawa; Y Kimura; K Hiromatsu; N Kobayashi; A Yamada; M Makino; M Okuda; T Sano; K Nomoto; Y Yoshikai
IMMUNOPHARMACOLOGY, 1997年01月 - Development of cancer vaccine by tumor rejection antigens
Kyogo Itoh; Akihiro Hayashi; Yuji Toh; Yasuhisa Imai; Akira Yamada; Takashi Nishida; Shigeki Shichijo
International Reviews of Immunology, 1997年 - Cytokine messenger RNA expression in the labial salivary glands of patients with Sjogren's syndrome
Y Ohyama; S Nakamura; G Matsuzaki; M Shinohara; A Hiroki; T Fujimura; A Yamada; K Itoh; K Nomoto
ARTHRITIS AND RHEUMATISM, 1996年08月 - Induction of MAGE genes in lymphoid cells by the demethylating agent 5-aza-2'-deoxycytidine
S Shichijo; A Yamada; K Sagawa; O Iwamoto; M Sakata; K Nagai; K Itoh
JAPANESE JOURNAL OF CANCER RESEARCH, 1996年07月 - A monoclonal antibody KIS-1 recognizing a new membrane antigen on human squamous-cell carcinoma
U Toh; H Yamana; H Fujita; Y Toh; T Fujii; K Kubo; A Yamada; S Shichijo; K Itoh
INTERNATIONAL JOURNAL OF CANCER, 1996年05月 - A novel monoclonal antibogy mNI-58A against the α-chain of leukocyte function-associated antigen-1(LFA-1) blockes the morphological changes in the phorbol myristate acetate(PMA)-Tissue Antigens
1996年 - TCR gamma delta+ T cells in peripheral blood of patients with adult Still's disease
T Hoshino; A Ohta; M Nakao; T Ota; T Inokuchi; S Matsueda; R Gouhara; A Yamada; K Itoh; K Oizumi
JOURNAL OF RHEUMATOLOGY, 1996年01月 - IMMUNOHISTOCHEMICALLY DEFINED LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 (LFA-1) ON AN ADENOCARCINOMA CELL-LINE IS A DISTINCT MOLECULE FROM LFA-1 ON LEUKOCYTES
A YAMADA; Y IMAI; T HOSHINO; K KUBO
CELLULAR IMMUNOLOGY, 1995年12月 - Expression of MAGE-1, MAGE-2, MAGE-3/-6 and MAGE-4a/-4b genes in ovarian tumors
A Yamada; A Kataoka; S Shichijo; T Kamura; Y Imai; T Nishida; K Itoh
INTERNATIONAL JOURNAL OF CANCER, 1995年12月 - IMMUNOHISTOCHEMICALLY DEFINED LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 (LFA-1) ON AN ADENOCARCINOMA CELL-LINE IS A DISTINCT MOLECULE FROM LFA-1 ON LEUKOCYTES
A YAMADA; Y IMAI; T HOSHINO; K KUBO
CELLULAR IMMUNOLOGY, 1995年12月 - SPONTANEOUS PRODUCTION OF VARIOUS CYTOKINES EXCEPT IL-4 FROM CD4(+) T-CELLS IN THE AFFECTED ORGANS OF SARCOIDOSIS PATIENTS
T HOSHINO; K ITOH; R GOUHARA; A YAMADA; Y TANAKA; Y ICHIKAWA; M AZUMA; M MOCHIZUKI; K OIZUMI
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995年11月 - SEQUENCE-ANALYSIS OF THE MAGE GENE FAMILY ENCODING HUMAN TUMOR-REJECTION ANTIGENS
Y IMAI; S SHICHIJO; A YAMADA; T KATAYAMA; H YANO; K ITOH
GENE, 1995年07月 - Expression of MAGE‐1, MAGE‐2, MAGE‐3/‐6 and MAGE‐4A/‐4B genes in ovarian tumors
Akira Yamada; Akio Kataoka; Shigeki Shichijo; Toshiharu Kamura; Yasuhisa Imai; Takashi Nishida; Kyogo Itoh
International Journal of Cancer, 1995年 - A NOVEL ANTIGEN (H47 AG) ON HUMAN-LYMPHOCYTES INVOLVED IN T-CELL ACTIVATION
N HIROHASHI; M NAKAO; K KUBO; A YAMADA; S SHICHIJO; A HARA; K SAGAWA; K ITOH
CELLULAR IMMUNOLOGY, 1993年12月 - LFA-1 EXPRESSION ON EXOCRINE GLANDS AS A POTENTIAL NOVEL MARKER OF MALIGNANT DISEASE
E FUTAGAMIMIZOGUCHI; A YAMADA; A MIZOGUCHI; Y IMAI; MM YOKOYAMA
AMERICAN JOURNAL OF PATHOLOGY, 1993年09月 - TISSUE-SPECIFIC DISTRIBUTION AND AGE-DEPENDENT INCREASE OF HUMAN CD11B+ T-CELLS
T HOSHINO; A YAMADA; J HONDA; Y IMAI; M NAKAO; M INOUE; K SAGAWA; MM YOKOYAMA; K OIZUMI; K ITOH
JOURNAL OF IMMUNOLOGY, 1993年08月 - ENHANCEMENT OF IMMUNOGLOBULIN-A PRODUCTION IN PEYERS-PATCHES BY ORAL-ADMINISTRATION OF A TRADITIONAL CHINESE MEDICINE, XIAO-CHAI-HU-TANG (SHOSAIKO-TO)
Y TAUCHI; A YAMADA; T KAWAKITA; Y SAITO; A SUZUKI; Y YOSHIKAI; K NOMOTO
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1993年 - PROTECTIVE EFFECT OF REN-SHEN-YANG-RONG-TANG (NINJIN-YOUEI-TO) IN MICE WITH DRUG-INDUCED LEUKOPENIA AGAINST PSEUDOMONAS-AERUGINOSA INFECTION
S MIURA; H TAKIMOTO; Y YOSHIKAI; Y KUMAZAWA; A YAMADA; K NOMOTO
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992年10月 - CD45 ISOFORM EXPRESSION ON HUMAN NEONATAL T-CELLS - EXPRESSION AND TURNOVER OF CD45 ISOFORMS ON NEONATAL VERSUS ADULT T-CELLS AFTER ACTIVATION
A YAMADA; T KANEYUKI; A HARA; DM ROTHSTEIN; MM YOKOYAMA
CELLULAR IMMUNOLOGY, 1992年06月 - CD45 ISOFORM EXPRESSION ON HUMAN NEONATAL T-CELLS - EXPRESSION AND TURNOVER OF CD45 ISOFORMS ON NEONATAL VERSUS ADULT T-CELLS AFTER ACTIVATION
A YAMADA; T KANEYUKI; A HARA; DM ROTHSTEIN; MM YOKOYAMA
CELLULAR IMMUNOLOGY, 1992年06月 - SIGNALING FROM LFA-1 CONTRIBUTES SIGNAL TRANSDUCTION THROUGH CD2 ALTERNATIVE PATHWAY IN T-CELL ACTIVATION
A YAMADA; T KANEYUKI; Y TORIMOTO; JF DALEY; CM PRADO; MM YOKOYAMA
CELLULAR IMMUNOLOGY, 1992年06月 - Signaling from LFA-1 contributes signal transduction through CD2 alternative pathway in T cell activation
Akira Yamada; Takako Kaneyuki; Yoshihiro Torimoto; John F. Daley; Catherine M. Prado; Mitchel M. Yokoyama
Cellular Immunology, 1992年 - CD45 ISOFORMS ASSOCIATED WITH DISTINCT FUNCTIONS OF CD4 CELLS DERIVED FROM UNUSUAL HEALTHY DONORS LACKING CD45RA - LYMPHOCYTES-T
T MATSUYAMA; A YAMADA; DM ROTHSTEIN; KC ANDERSON; SF SCHLOSSMAN; C MORIMOTO
CELLULAR IMMUNOLOGY, 1991年10月 - CYTOCHALASINS ENHANCE THE PROLIFERATION OF CD4 CELLS THROUGH THE CD3-TI ANTIGEN RECEPTOR COMPLEX OR THE CD2 MOLECULE THROUGH AN EFFECT ON EARLY EVENTS OF ACTIVATION
T MATSUYAMA; A YAMADA; K DEUSCH; J SLEASMAN; JF DALEY; Y TORIMOTO; T ABE
JOURNAL OF IMMUNOLOGY, 1991年06月 - CROSS-LINKING OF VLA/CD29 MOLECULE HAS A CO-MITOGENIC EFFECT WITH ANTI-CD3 ON CD4 CELL ACTIVATION IN SERUM-FREE CULTURE SYSTEM
A YAMADA; Y NOJIMA; K SUGITA; NH DANG; SF SCHLOSSMAN; C MORIMOTO
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991年02月 - CYCLIC REGULATION OF CD45 ISOFORM EXPRESSION IN A LONG-TERM HUMAN CD4+CD45RA+ T-CELL LINE
DM ROTHSTEIN; A YAMADA; SF SCHLOSSMAN; C MORIMOTO
JOURNAL OF IMMUNOLOGY, 1991年02月 - CROSS-LINKING OF VLA/CD29 MOLECULE HAS A CO-MITOGENIC EFFECT WITH ANTI-CD3 ON CD4 CELL ACTIVATION IN SERUM-FREE CULTURE SYSTEM
A YAMADA; Y NOJIMA; K SUGITA; NH DANG; SF SCHLOSSMAN; C MORIMOTO
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991年02月 - ACTIVATION OF HUMAN CD4 LYMPHOCYTES-T - INTERACTION OF FIBRONECTIN WITH VLA-5 RECEPTOR ON CD4 CELLS INDUCES THE AP-1 TRANSCRIPTION FACTOR
A YAMADA; T NIKAIDO; Y NOJIMA; SF SCHLOSSMAN; C MORIMOTO
JOURNAL OF IMMUNOLOGY, 1991年01月 - ACTIVATION OF HUMAN CD4 LYMPHOCYTES-T - INTERACTION OF FIBRONECTIN WITH VLA-5 RECEPTOR ON CD4 CELLS INDUCES THE AP-1 TRANSCRIPTION FACTOR
A YAMADA; T NIKAIDO; Y NOJIMA; SF SCHLOSSMAN; C MORIMOTO
JOURNAL OF IMMUNOLOGY, 1991年01月 - EFFECT OF ACTIVATION OF PROTEIN-KINASE-C ON CD45 ISOFORM EXPRESSION AND CD45 PROTEIN TYROSINE PHOSPHATASE-ACTIVITY IN T-CELLS
A YAMADA; M STREULI; H SAITO; DM ROTHSTEIN; SF SCHLOSSMAN; C MORIMOTO
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990年08月 - EFFECT OF ACTIVATION OF PROTEIN-KINASE-C ON CD45 ISOFORM EXPRESSION AND CD45 PROTEIN TYROSINE PHOSPHATASE-ACTIVITY IN T-CELLS
A YAMADA; M STREULI; H SAITO; DM ROTHSTEIN; SF SCHLOSSMAN; C MORIMOTO
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990年08月 - ACTIVATION OF CD4 CELLS BY FIBRONECTIN AND ANTI-CD3 ANTIBODY - A SYNERGISTIC EFFECT MEDIATED BY THE VLA-5 FIBRONECTIN RECEPTOR COMPLEX
T MATSUYAMA; A YAMADA; J KAY; KM YAMADA; SK AKIYAMA; SF SCHLOSSMAN; C MORIMOTO
JOURNAL OF EXPERIMENTAL MEDICINE, 1989年10月 - EFFECT OF A TRADITIONAL CHINESE HERBAL MEDICINE, REN-SHEN-YANG-RONG-TANG (JAPANESE NAME - NINJIN-YOUEI-TO) ON HEMATOPOIETIC STEM-CELLS IN MICE
S MIURA; KAWAMURA, I; A YAMADA; T KAWAKITA; Y KUMAZAWA; K HIMENO; K NOMOTO
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1989年 - REGULATION OF FC-GAMMA-2A RECEPTOR-MEDIATED PHAGOCYTOSIS BY A MURINE MACROPHAGE-LIKE CELL-LINE, P388D1 - INVOLVEMENT OF CASEIN KINASE-II ACTIVITY ASSOCIATED WITH FC-GAMMA-2A RECEPTOR
A YAMADA; KN DILEEPAN; DJ STECHSCHULTE; T SUZUKI
JOURNAL OF MOLECULAR AND CELLULAR IMMUNOLOGY, 1989年 - ACTIVATION OF MURINE PERITONEAL-MACROPHAGES BY INTRAPERITONEAL ADMINISTRATION OF A TRADITIONAL CHINESE HERBAL MEDICINE, XIAO-CHAI-HU-TANG (JAPANESE NAME, SHOSAIKO-TO)
Y KUMAZAWA; H TAKIMOTO; SI MIURA; C NISHIMURA; A YAMADA; T KAWAKITA; K NOMOTO
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1988年 - PROTECTIVE EFFECT OF A TRADITIONAL CHINESE-MEDICINE, XIAO-CHAI-HU-TANG (JAPANESE NAME - SHOSAIKO-TO), ON LISTERIA-MONOCYTOGENES INFECTION IN MICE
T KAWAKITA; A YAMADA; M MITSUYAMA; Y KUMAZAWA; K NOMOTO
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1988年 - ANTIGEN-SPECIFIC AUGMENTATION FACTOR INVOLVED IN MURINE DELAYED-TYPE FOOTPAD REACTION .3. GENETIC RESTRICTION OF DELAYED-HYPERSENSITIVITY AUGMENTATION FACTOR (DAF)
A YAMADA; K HIMENO; S NAKAMURA; K NOMOTO
IMMUNOBIOLOGY, 1987年12月 - TRANSFER OF RESISTANCE TO PRIMARY INFECTION OF LISTERIA-MONOCYTOGENES AND EARLY INDUCTION OF DELAYED-HYPERSENSITIVITY BY SERA FROM L-MONOCYTOGENES-INFECTED MICE
A YAMADA; K HIMENO; S NAKAMURA; KAWAMURA, I; K NOMOTO
INFECTION AND IMMUNITY, 1987年12月 - ANTIGEN-SPECIFIC AUGMENTATION FACTOR INVOLVED IN MURINE DELAYED-TYPE FOOTPAD REACTION .4. EFFECT OF DELAYED-TYPE HYPERSENSITIVITY AUGMENTATION FACTOR ON INVITRO INDUCTION OF DTH
S NAKAMURA; K HIMENO; A YAMADA; KAWAMURA, I; K NOMOTO
CELLULAR IMMUNOLOGY, 1987年03月 - PROTECTIVE EFFECT OF A TRADITIONAL CHINESE-MEDICINE, XIAO-CHAI-HU-TANG (JAPANESE NAME SHOSAIKO-TO), ON PSEUDOMONAS-AERUGINOSA INFECTION IN MICE
T KAWAKITA; A YAMADA; M MITSUYAMA; Y KUMAZAWA; K NOMOTO
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1987年 - FUNCTIONAL MATURATION OF IMMATURE B-CELLS ACCUMULATED IN THE PERIPHERY BY AN INTRAPERITONEAL ADMINISTRATION OF A TRADITIONAL CHINESE-MEDICINE, XIAO-CHAI-HU-TANG (JAPANESE NAME - SHOSAIKO-TO)
T KAWAKITA; A YAMADA; Y KUMAZAWA; K NOMOTO
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1987年 - ANTIGEN-SPECIFIC AUGMENTATION FACTOR INVOLVED IN MURINE DELAYED-TYPE FOOTPAD REACTION .2. AUGMENTATION OF DELAYED-TYPE FOOTPAD REACTION AND ACQUIRED-RESISTANCE TO LISTERIA-MONOCYTOGENES BY TRANSFER OF LISTERIA-IMMUNE SERUM
K HIMENO; A YAMADA; T KAWAKITA; S NAKAMURA; M MITSUYAMA; K NOMOTO
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1987年 - ANTIGEN-SPECIFIC AUGMENTATION OF DELAYED-TYPE HYPERSENSITIVITY BY IMMUNE SERUM FACTOR IN MICE - AUGMENTATION OF ANTITUMOR CYTOSTATIC ACTIVITY
S NAKAMURA; K HIMENO; A YAMADA; M MITANI; K NOMOTO
CELLULAR IMMUNOLOGY, 1986年12月 - EFFECT OF INCREASE IN MACROPHAGE IA EXPRESSION ON SUBSEQUENT IMMUNE-RESPONSE INVIVO
T KOGA; M MITSUYAMA; Y WATANABE; A YAMADA; Y YOSHIKAI; K NOMOTO
JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY, 1986年05月 - ACCUMULATION OF IMMATURE LYMPHOCYTES-B AND NULL LYMPHOCYTES IN THE PERIPHERY AFTER INTRAPERITONEAL ADMINISTRATION OF TRADITIONAL CHINESE-MEDICINE, XIAO-CHAI-HU-TANG (JAPANESE NAME, SHOSAIKO-TO)
T KAWAKITA; A YAMADA; Y KUMAZAWA; K NOMOTO
JOURNAL OF IMMUNOPHARMACOLOGY, 1986年 - ALLOGENEIC CYTO-TOXIC LYMPHOCYTES-T ARE AUGMENTED INVIVO BY A FRACTION OF SRBC-IMMUNE MOUSE SERUM CONTAINING LITTLE PROTEIN
K KAMIKASEDA; T OHMORI; A YAMADA; S TSURU; K TANIGUCHI; K NOMOTO
JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY, 1985年 - ANTIGEN-SPECIFIC AUGMENTATION OF DELAYED-TYPE HYPERSENSITIVITY BY IMMUNE SERUM FACTOR IN MICE
K HIMENO; A YAMADA; H MIYATA; F NANISHI; K NOMOTO
CELLULAR IMMUNOLOGY, 1985年 - ANTIGEN-SPECIFIC AUGMENTATION OF MURINE IMMEDIATE HYPERSENSITIVITY-LIKE FOOTPAD REACTION BY A T-CELL FACTOR IN THE CULTURE SUPERNATANT OF IMMUNE SPLEEN-CELLS
A YAMADA; K HIMENO; Y KUMAZAWA; K NOMOTO
CELLULAR IMMUNOLOGY, 1985年 - IMMUNOPOTENTIATOR SEPARATED FROM HOT WATER EXTRACT OF THE SEED OF BENINCASA-CERIFERA SAVI (TOHGASHI)
Y KUMAZAWA; Y NAKATSURU; A YAMADA; T YADOMAE; C NISHIMURA; Y OTSUKA; K NOMOTO
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1985年 - ANTIGEN-SPECIFIC AUGMENTATION FACTOR INVOLVED IN MURINE DELAYED-TYPE FOOTPAD REACTION .1. NATURE OF AUGMENTATION FACTOR
A YAMADA; K HIMENO; H MIYATA; Y KUMAZAWA; K NOMOTO
CELLULAR IMMUNOLOGY, 1984年 - ACTIVATION OF DISTINCT T-CELL SUBSETS INVOLVED IN IGM ANTIBODY-RESPONSE OF MICE BY PERTUSSIS TOXIN FROM BORDETELLA-PERTUSSIS STRAIN MAENO
Y KUMAZAWA; A YAMADA; A OHTANI; H FUJISAWA; C NISHIMURA; K MIZUNOE
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1984年 - ANTIGEN-SPECIFIC AUGMENTATION OF DELAYED-TYPE HYPERSENSITIVITY BY A HUMORAL FACTOR IN THE CULTURE SUPERNATANT OF IMMUNE SPLEEN-CELLS
A YAMADA; K HIMENO; Y KUMAZAWA; K NOMOTO
CELLULAR IMMUNOLOGY, 1984年 - N. Tsuda, Y. Nonaka, S. Shichijo, A. Yamada, M. Ito, Y. Maeda, M.Harada, T. Kamura, K. Itoh. UDP-Gal: βGlcNAc β1, 3-Galactosyltransferase, Polypeptide 3 (GALT3) is a Tumor Antigen Recognized by HLA-A2-Restricted Cytotoxic T Lymphocytes from Patients wi・・・
Br. J. Cancer
- Peptide encoded by an intron of the putative tumor suppressor gene Testin of the common fragile site 7G is a cancer antigen recognized by cytotoxic T lymphocytes. In “FRAGILE SITES: New discoveries and changing perspectives”
Yamada A, Itoh K., 分担執筆
Eds: Isabel Arrieta, Olga Penagarikano, and Mercedes Telez. Nova Science Publishers Inc. Hauppauge NY., 2007年 - Peptide-based vaccines for cancer immunotherapy. In "Current Topics in Peptide & Protein Research"
A. Yamada, H. Yamana, K. Itoh. (R. M. Mohan, ed.), 分担執筆
Research Trend, India, 2004年 - Development of peptide-based vaccines for epithelial cancer. In "Research Progress in Cancer 2"
A. Yamada, H. Yamana, K. Itoh. (R. M. Mohan, ed.), 分担執筆
Global Research Network, India., 2002年 - A. Yamada, H. Yamana, K. Itoh. Development of peptide-based vaccines for epithelial cancer. In “Research Progress in Cancer 2”, R. M. Mohan (Ed), Global Research Network, India. pp. 241-247, 2002."
2002年, 査読無し - A. Yamada, H. Yamana, K. Itoh. Development of Peptide-Based Vaccines for Epithelial Cancer. In “ Research Progress in Cancer 2”, R. M. Mohan(Ed), Global
Research Network, Ind, 2002年, 査読無し - Immunopotentiating effects of a glycoprotein from Chlorella vulgaris strain CK and its characteristics.
K. Tanaka, Y. Shoyama, A. Yamada, K. Noda, F. Konishi, and K. Nomoto. (Atta-ur-Rahman, eds.), 分担執筆
Bioactive Natural Products (Part F). Elsevier Science, Oxford., 2001年 - K. Tanaka, Y. Shoyama, A. Yamada, K. Noda, F. Konishi, and K. Nomoto. Immunopotentiating Effects of a Glycoprotein from Chlorella Vulgaris Strain CK and its Characteristics In “ Studies in Natural Products Chemistry (Atta-ur-Rahman, eds), Vol25 Bioacti・・・
Elsevier Science, Oxford, 2001年, 査読無し - K. Itoh, Y. Imai, T. Kuramoto, A. Yamada, H. Yamana, and S. Shichijo. Exprssion of MAGE-1 and –4 Proteins in Normal Tissues and Various Cancers. In “ Melanogenesis and Malignant Melanoma” , Y. Hori, V. J. Hearing, J. Nakayama (Eds)
Elsevier Science, Amsterdam, 1996年, 査読無し - Expression of MAGE-1 and -4 proteins in normal tissues and various cancers.
"Melanogenesis and malignant melanoma", Y. Hori, V. J. Hearing, J. Nakayama (Eds). Elsevier Science, Amsterdam., 1996年, 査読無し
■ 所属学協会
- 1980年 - 2022年
日本免疫学会 - 2001年 - 2021年
日本癌治療学会 - 2002年 - 2020年
日本臨床薬理学会 - 2001年 - 2020年
日本薬学会 - 2004年
米国癌学会 - 1997年
日本がん免疫学会 - 1993年
日本癌学会 - 1992年
米国免疫学会 - 基盤的癌免疫研究会
- 日本生体防御学会
- 日本細菌学会
■ 共同研究・競争的資金等の研究課題
- HMGB1の抗腫瘍免疫における機能解明とがん免疫療法への応用
2020年 - HMGB1の抗腫瘍免疫における機能解明とがん免疫療法への応用
2019年 - すこやかな次代と人を創る研究拠点大学へ:先端的がん治療研究による挑戦
2017年 - 次世代経皮カクテルワクチンの開発基礎研究
2016年 - 次世代経皮カクテルワクチンの開発基礎研究
2015年 - 次世代経皮カクテルワクチンの開発基礎研究
2014年 - マルチペプチド混合がんワクチンの開発基礎研究
2013年 - マルチペプチド混合がんワクチンの開発基礎研究
2012年 - がんペプチドワクチンの研究開発拠点
2011年 - マルチペプチド混合がんワクチンの開発基礎研究
2011年 - 肺がん、肝臓がん及び膀胱がん症例に対するテーラーメイドがんペプチドワクチン療法の実用化研究
2010年 - C型肝炎ウイルスに対するペプチドワクチン開発の基盤的研究
2010年 - 癌およびC型肝炎ウイルス感染症へのペプチドワクチン開発の基礎及び臨床研究
2010年 - 肺がん、肝臓がん及び膀胱がん症例に対するテーラーメイドがんペプチドワクチン療法の実用化研究
2009年 - C型肝炎ウイルスに対するペプチドワクチン開発の基盤的研究
2009年 - 癌およびC型肝炎ウイルス感染症へのペプチドワクチン開発の基礎及び臨床研究
2009年 - C型肝炎ウイルスに対するペプチドワクチン開発の基盤的研究
2008年 - マルチペプチド混合がんワクチンの開発基礎研究:ポストテーラーメイドワクチンの開発
2008年 - 癌およびC型肝炎ウイルス感染症へのペプチドワクチン開発の基礎及び臨床研究
2008年 - C型肝炎ウイルスに対するペプチドワクチン開発の基盤的研究
2007年 - 癌およびC型肝炎ウイルス感染症へのペプチドワクチン開発の基礎及び臨床研究
2007年 - C型肝炎ウイルスに対するペプチドワクチン開発の基盤的研究
2006年 - 癌およびC型肝炎ウイルス感染症へのペプチドワクチン開発の基礎及び臨床研究
2006年 - C型肝炎ウイルス感染者への治療用ペプチドワクチン開発
2006年 - 先端的な癌治療研究の拠点
2006年 - 新規肺癌抗原の同定とそれらを分子標的としたペプチドワクチンの開発
2005年 - C型肝炎ウイルスに対する新規診断薬と治療法の開発
2005年 - 先端的な癌治療研究の拠点
2005年 - 新規肺癌抗原の同定とそれらを分子標的としたペプチドワクチンの開発
2004年 - C型肝炎ウイルスに対する新規診断薬と治療法の開発
2004年 - 先端的な癌治療研究の拠点
2004年 - 婦人科領域上皮性癌拒絶抗原の同定とがんワクチン分子開発
2003年 - 癌ワクチン療法に関する研究
2003年 - 新規肺癌抗原の同定とそれらを分子標的としたペプチドワクチンの開発
2003年 - 先端的な癌治療研究の拠点
2003年 - C型肝炎ウイルスに対する新規診断薬と治療法の開発
2003年 - 婦人科領域上皮性癌拒絶抗原の同定と癌ワクチン分子開発
2002年 - 婦人科領域上皮性癌拒絶抗原の同定と癌ワクチン分子開発
2001年 - 婦人科領域上皮性癌拒絶抗原の同定と癌ワクチン分子開発
2000年 - ヒトリンパ球上の細胞接着因子（VLA抗原）とその調節
1991年 - 白血病細胞の実質臓器内への浸潤機構、インテグリン分子による白血病細胞血管内皮細胞相互作用の解析
1990年 - 免疫関連の新規医薬品（機能性食品を含む）開発
- がんワクチンの開発研究
■ 共同研究希望
■ 共同研究実績
■ 研究者からの一言アピール
■ 関心を持って取組んでいる活動
